Intelligent Bio Solutions's quarterly market cap
increased
from Sep. 2023 ($2.40 Mil) to Dec. 2023 ($5.98 Mil) and
increased
from Dec. 2023 ($5.98 Mil) to Mar. 2024 ($12.30 Mil).
Intelligent Bio Solutions's annual market cap
declined
from Jun. 2021 ($53.51 Mil) to Jun. 2022 ($9.86 Mil) and
declined
from Jun. 2022 ($9.86 Mil) to Jun. 2023 ($6.47 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Intelligent Bio Solutions's Enterprise Value for Today is $-1.22 Mil.
Intelligent Bio Solutions Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Intelligent Bio Solutions's Market Cap
For the Medical Devices subindustry, Intelligent Bio Solutions's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intelligent Bio Solutions's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Intelligent Bio Solutions's Market Cap distribution charts can be found below:
* The bar in red indicates where Intelligent Bio Solutions's Market Cap falls into.
Intelligent Bio Solutions Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intelligent Bio Solutions (NAS:INBS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Intelligent Bio Solutions Market Cap Related Terms
Thank you for viewing the detailed overview of Intelligent Bio Solutions's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Intelligent Bio Solutions (Intelligent Bio Solutions) Business Description
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
INBS has been successfully added to your 